vs

Side-by-side financial comparison of KINGSWAY FINANCIAL SERVICES INC (KFS) and Pulmonx Corp (LUNG). Click either name above to swap in a different company.

KINGSWAY FINANCIAL SERVICES INC is the larger business by last-quarter revenue ($38.6M vs $20.6M, roughly 1.9× Pulmonx Corp). KINGSWAY FINANCIAL SERVICES INC runs the higher net margin — -4.1% vs -66.3%, a 62.2% gap on every dollar of revenue. On growth, KINGSWAY FINANCIAL SERVICES INC posted the faster year-over-year revenue change (30.1% vs -8.7%). Over the past eight quarters, KINGSWAY FINANCIAL SERVICES INC's revenue compounded faster (21.4% CAGR vs -0.5%).

Kingsway Financial Services Inc. is a specialty financial holding firm that primarily offers property and casualty insurance products, including personal auto, commercial liability and property coverage. It operates mainly across North American markets, catering to individual consumers, small business owners and niche commercial client segments.

Pulmonx Corp is a global medical tech firm focused on interventional pulmonology solutions. It develops minimally invasive endobronchial valves to treat severe COPD and emphysema, with products sold across North America, Europe, and Asia-Pacific for patients with advanced lung conditions.

KFS vs LUNG — Head-to-Head

Bigger by revenue
KFS
KFS
1.9× larger
KFS
$38.6M
$20.6M
LUNG
Growing faster (revenue YoY)
KFS
KFS
+38.7% gap
KFS
30.1%
-8.7%
LUNG
Higher net margin
KFS
KFS
62.2% more per $
KFS
-4.1%
-66.3%
LUNG
Faster 2-yr revenue CAGR
KFS
KFS
Annualised
KFS
21.4%
-0.5%
LUNG

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
KFS
KFS
LUNG
LUNG
Revenue
$38.6M
$20.6M
Net Profit
$-1.6M
$-13.7M
Gross Margin
77.9%
Operating Margin
0.8%
-40.9%
Net Margin
-4.1%
-66.3%
Revenue YoY
30.1%
-8.7%
Net Profit YoY
-7.8%
5.5%
EPS (diluted)
$-0.07
$-0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KFS
KFS
LUNG
LUNG
Q1 26
$20.6M
Q4 25
$38.6M
$22.6M
Q3 25
$37.2M
$21.5M
Q2 25
$30.9M
$23.9M
Q1 25
$28.3M
$22.5M
Q4 24
$29.6M
$23.8M
Q3 24
$27.1M
$20.4M
Q2 24
$26.4M
$20.8M
Net Profit
KFS
KFS
LUNG
LUNG
Q1 26
$-13.7M
Q4 25
$-1.6M
$-10.4M
Q3 25
$-2.4M
$-14.0M
Q2 25
$-3.2M
$-15.2M
Q1 25
$-3.1M
$-14.4M
Q4 24
$-1.5M
$-13.2M
Q3 24
$-2.3M
$-14.1M
Q2 24
$-2.2M
$-15.3M
Gross Margin
KFS
KFS
LUNG
LUNG
Q1 26
77.9%
Q4 25
77.6%
Q3 25
74.7%
Q2 25
72.1%
Q1 25
72.5%
Q4 24
74.0%
Q3 24
73.7%
Q2 24
73.7%
Operating Margin
KFS
KFS
LUNG
LUNG
Q1 26
-40.9%
Q4 25
0.8%
-43.8%
Q3 25
-2.3%
-66.9%
Q2 25
-3.6%
-62.0%
Q1 25
-2.5%
-64.6%
Q4 24
6.5%
-56.5%
Q3 24
-2.5%
-69.3%
Q2 24
0.5%
-75.2%
Net Margin
KFS
KFS
LUNG
LUNG
Q1 26
-66.3%
Q4 25
-4.1%
-46.1%
Q3 25
-6.5%
-64.9%
Q2 25
-10.2%
-63.6%
Q1 25
-10.9%
-64.1%
Q4 24
-5.0%
-55.4%
Q3 24
-8.5%
-69.4%
Q2 24
-8.3%
-73.7%
EPS (diluted)
KFS
KFS
LUNG
LUNG
Q1 26
$-0.33
Q4 25
$-0.07
$-0.25
Q3 25
$-0.10
$-0.34
Q2 25
$-0.13
$-0.38
Q1 25
$-0.13
$-0.36
Q4 24
$-0.08
$-0.33
Q3 24
$-0.10
$-0.36
Q2 24
$-0.08
$-0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KFS
KFS
LUNG
LUNG
Cash + ST InvestmentsLiquidity on hand
$8.5M
$61.6M
Total DebtLower is stronger
$70.7M
$37.3M
Stockholders' EquityBook value
$15.2M
$45.8M
Total Assets
$231.5M
$120.0M
Debt / EquityLower = less leverage
4.66×
0.82×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KFS
KFS
LUNG
LUNG
Q1 26
$61.6M
Q4 25
$8.5M
$69.8M
Q3 25
$9.5M
$76.5M
Q2 25
$12.3M
$75.5M
Q1 25
$6.5M
$74.6M
Q4 24
$5.7M
$70.9M
Q3 24
$6.7M
$63.3M
Q2 24
$9.8M
$63.5M
Total Debt
KFS
KFS
LUNG
LUNG
Q1 26
$37.3M
Q4 25
$70.7M
$37.1M
Q3 25
$70.7M
$37.1M
Q2 25
$58.3M
$37.1M
Q1 25
$59.5M
$37.2M
Q4 24
$57.5M
$37.2M
Q3 24
$58.5M
$37.2M
Q2 24
$47.3M
$37.2M
Stockholders' Equity
KFS
KFS
LUNG
LUNG
Q1 26
$45.8M
Q4 25
$15.2M
$54.1M
Q3 25
$16.6M
$60.0M
Q2 25
$17.4M
$69.1M
Q1 25
$5.5M
$77.7M
Q4 24
$8.4M
$85.8M
Q3 24
$9.9M
$93.9M
Q2 24
$20.7M
$101.2M
Total Assets
KFS
KFS
LUNG
LUNG
Q1 26
$120.0M
Q4 25
$231.5M
$129.3M
Q3 25
$235.1M
$138.3M
Q2 25
$207.7M
$147.2M
Q1 25
$192.1M
$150.7M
Q4 24
$186.6M
$162.8M
Q3 24
$191.1M
$167.4M
Q2 24
$192.3M
$172.6M
Debt / Equity
KFS
KFS
LUNG
LUNG
Q1 26
0.82×
Q4 25
4.66×
0.69×
Q3 25
4.25×
0.62×
Q2 25
3.34×
0.54×
Q1 25
10.91×
0.48×
Q4 24
6.84×
0.43×
Q3 24
5.88×
0.40×
Q2 24
2.29×
0.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KFS
KFS
LUNG
LUNG
Operating Cash FlowLast quarter
$-3.0K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KFS
KFS
LUNG
LUNG
Q1 26
Q4 25
$-3.0K
$-7.1M
Q3 25
$1.5M
$-8.2M
Q2 25
$337.0K
$-3.9M
Q1 25
$-1.8M
$-13.2M
Q4 24
$1.1M
$-6.7M
Q3 24
$368.0K
$-7.2M
Q2 24
$557.0K
$-5.8M
Free Cash Flow
KFS
KFS
LUNG
LUNG
Q1 26
Q4 25
$-7.1M
Q3 25
$1.3M
$-8.3M
Q2 25
$-4.0M
Q1 25
$-13.5M
Q4 24
$-6.8M
Q3 24
$-7.7M
Q2 24
$-6.2M
FCF Margin
KFS
KFS
LUNG
LUNG
Q1 26
Q4 25
-31.4%
Q3 25
3.4%
-38.4%
Q2 25
-16.6%
Q1 25
-60.0%
Q4 24
-28.8%
Q3 24
-37.6%
Q2 24
-30.0%
Capex Intensity
KFS
KFS
LUNG
LUNG
Q1 26
Q4 25
0.1%
Q3 25
0.5%
0.4%
Q2 25
0.2%
Q1 25
1.3%
Q4 24
0.5%
Q3 24
0.0%
2.0%
Q2 24
2.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KFS
KFS

Other$14.8M38%
Roundhouse Electric Equipment Co Inc$9.7M25%
MLC Plumbing LLC$5.7M15%
Systems Products International Incspi$3.8M10%
Advanced Plumbing And Drain$2.9M8%
Southside Plumbing$1.7M4%

LUNG
LUNG

Segment breakdown not available.

Related Comparisons